PROTEIN INGREDIENTS

Brand Owner (click to sort) Address Description
BEVWISE GLANBIA NUTRITIONALS LIMITED Glanbia House Kilkenny R95E866 Ireland Protein ingredients, namely, whey protein and milk/soy protein blends, in powder form for use in the manufacture of ready to drink beverages;
NEXT GENERATION PROTEINS Socius Ingredients 1033 University Place, Suite 110 Evanston IL 60201 Protein ingredients, namely, plant protein concentrates and isolates as ingredients for use in the manufacture of processed food, foodstuffs and beverages and protein/hydrocolloid blends as ingredients for use in the manufacture of processed food, foodstuffs and beverages;PROTEINS;
NPRO Socius Ingredients Suite 110 1033 University Place Evanston IL 60201 Protein ingredients, namely, whey proteins and potato proteins, for use as ingredients in the manufacture of processed food, foodstuffs and beverages;
PLANTEC Socius Ingredients 1033 University Place, Suite 110 Evanston IL 60201 Protein ingredients, namely, plant protein concentrates and isolates as ingredients for use in the manufacture of processed food, foodstuffs and beverages and protein/hydrocolloid blends as ingredients for use in the manufacture of processed food, foodstuffs and beverages;
SO-PRO Socius Ingredients 1033 University Place, Suite 110 Evanston IL 60201 Protein ingredients, namely, casein, caseinates, whey proteins, milk protein concentrates and non-dairy proteins for use as ingredients in the manufacture of processed food, foodstuffs and beverages;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The objects of the present invention are to reveal a specific combination of human interferon-? subtypes that remarkably enhances the expression of protein synthesis inhibitory genes, and to provide an expression enhancer comprising as effective ingredients interferon-? subtypes in such a combination and uses thereof. The above objects are solved by providing an expression enhancer for protein synthesis inhibitory genes which comprises as effective ingredients interferon-?2 and interferon-?8 subtypes of human interferon-?, and uses thereof including pharmaceuticals.